92 related articles for article (PubMed ID: 31828139)
1. Acute aflatoxin B1 - Induced hepatotoxicity alters gene expression and disrupts lipid and lipoprotein metabolism in rats.
Rotimi OA; Rotimi SO; Duru CU; Ebebeinwe OJ; Abiodun AO; Oyeniyi BO; Faduyile FA
Toxicol Rep; 2017; 4():408-414. PubMed ID: 28959666
[TBL] [Abstract][Full Text] [Related]
2. Recent Progress on Lipid Intake and Chronic Kidney Disease.
Pei K; Gui T; Li C; Zhang Q; Feng H; Li Y; Wu J; Gai Z
Biomed Res Int; 2020; 2020():3680397. PubMed ID: 32382547
[TBL] [Abstract][Full Text] [Related]
3. Age-Related Changes in Serum Lipid Levels, Hepatic Morphology, Antioxidant Status, Lipid Metabolism Related Gene Expression and Enzyme Activities of Domestic Pigeon Squabs (
Xu Q; Li H; Zhou W; Zou X; Dong X
Animals (Basel); 2020 Jul; 10(7):. PubMed ID: 32630261
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidemic effect and activation of Lecithin Cholesterol Acyl Transferase (LCAT) by aqueous extract of
Ama Moor VJ; Nya Biapa PC; Nono Njinkio BL; Moukette Moukette B; Sando Z; Kenfack C; Ateba B; Ngo Matip ME; Pieme CA; Ngogang J
BMC Nutr; 2017; 3():25. PubMed ID: 32153807
[TBL] [Abstract][Full Text] [Related]
5. Bioactive lipids are altered in the kidney of chronic undernourished rats: is there any correlation with the progression of prevalent nephropathies?
Sampaio LS; da Silva PA; Ribeiro VS; Castro-Chaves C; Lara LS; Vieyra A; Einicker-Lamas M
Lipids Health Dis; 2017 Dec; 16(1):245. PubMed ID: 29246161
[TBL] [Abstract][Full Text] [Related]
6. Adenine-induced animal model of chronic kidney disease: current applications and future perspectives.
Yang Q; Su S; Luo N; Cao G
Ren Fail; 2024 Dec; 46(1):2336128. PubMed ID: 38575340
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations.
Al-Moussally F; Thompson BM; Masarweh OM; Shah N; Gaudi S; Restrepo J
Cureus; 2024 May; 16(5):e61071. PubMed ID: 38915973
[TBL] [Abstract][Full Text] [Related]
8. Functional food mixtures: Inhibition of lipid peroxidation, HMGCoA reductase, and ACAT2 in hypercholesterolemia-induced rats.
Mohd Rosmi NSA; Shafie NH; Azlan A; Abdullah MA
Food Sci Nutr; 2021 Feb; 9(2):875-887. PubMed ID: 33598171
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients.
Eslami Z; Aghili SS; Ghafi AG
Chonnam Med J; 2024 Jan; 60(1):13-20. PubMed ID: 38304133
[TBL] [Abstract][Full Text] [Related]
10. Panax notoginseng saponins alleviate damage to the intestinal barrier and regulate levels of intestinal microbes in a rat model of chronic kidney disease.
Xie J; Ma X; Zheng Y; Mao N; Ren S; Fan J
Ren Fail; 2022 Dec; 44(1):1948-1960. PubMed ID: 36354128
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
Liang K; Kim CH; Vaziri ND
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
[TBL] [Abstract][Full Text] [Related]
12. Niacin improves renal lipid metabolism and slows progression in chronic kidney disease.
Cho KH; Kim HJ; Kamanna VS; Vaziri ND
Biochim Biophys Acta; 2010 Jan; 1800(1):6-15. PubMed ID: 19878707
[TBL] [Abstract][Full Text] [Related]
13. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
Vaziri ND
Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
Yee HS; Fong NT
Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats.
Ghelani H; Razmovski-Naumovski V; Inampudi V; Chang D; Nammi S
Biomed Res Int; 2019; 2019():8714363. PubMed ID: 31828139
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment of curcumin improves hepatic lipid metabolism and alleviates the renal damage in adenine-induced chronic kidney disease in Sprague-Dawley rats.
Ghelani H; Razmovski-Naumovski V; Chang D; Nammi S
BMC Nephrol; 2019 Nov; 20(1):431. PubMed ID: 31752737
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
